iRhythm Technologies, Inc. (NASDAQ:IRTC) Q2 2023 Earnings Conference Call August 3, 2023 4:30 PM ET
Company Participants
Stephanie Zhadkevich - Director of Investor Relations
Quentin Blackford - President and Chief Executive Officer
Brice Bobzien - Chief Financial Officer
Daniel Wilson - Executive Vice President of Corporate Development and Investor Relations
Conference Call Participants
Margaret Kaczor - William Blair
Lily Lozada - JPMorgan
Kallum Titchmarsh - Morgan Stanley
Marie Thibault - BTIG LLC
Samuel Brodovsky - Truist Securities
Nathan Treybeck - Wells Fargo
David Rescott - Baird
David Saxon - Needham
John Young - Canaccord Genuity Corp.
Suraj Kalia - Oppenheimer
Michael Polark - Wolfe Research
Operator
Hello, and welcome to today’s iRhythm Technologies, Inc. Q2 2023 Earnings Conference Call. My name is Bailey, and I will be your moderator for today’s call. All lines will be muted during the presentation portion of the call with an opportunity for questions and answers at the end. [Operator Instructions]
I would now like to pass the conference over to our host, Stephanie Zhadkevich. Please go ahead.
Stephanie Zhadkevich
Thank you, all, for participating in today’s call. Earlier today, iRhythm released financial results for the second quarter ended June 30, 2023.
Before we begin, I’d like to remind you that management will make statements during this call that include forward-looking statements within the meaning of federal securities laws pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995.
Any statements contained in this call that are not statements of historical fact should be deemed to be forward-looking statements. These are based upon our current estimates and various assumptions and reflect management’s intentions, beliefs and expectations about future events, strategies, competition, products, operating plans and performance. These statements include risks and uncertainties that could cause actual results or events to materially differ from those anticipated or implied by these forward-looking statements.
Accordingly, you should not place undue reliance on these statements. For a list and description of the risks and uncertainties associated with our business, please refer to the Risk Factors section of our most recent annual and quarterly reports on Form 10-K and Form 10-Q, respectively, filed with the Securities and Exchange Commission.
Also during the call, we will discuss certain financial measures that have not been prepared in accordance with U.S. GAAP with respect to our non-GAAP and cash-based results, including adjusted EBITDA, adjusted operating expenses and adjusted net loss. Unless otherwise noted, all references to financial metrics are presented on a non-GAAP basis. The presentation of additional information should not be considered in isolation of as a substitute for or superior to results prepared in accordance with GAAP.